PROK
ProKidney Corp.
1.60$
+1.2%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | +202.6% | -3.9% | -1.8% | +3.7% | +0.4% | -33.6% | – | |
| – | +19.7% | -19.3% | +15.9% | +24.4% | -243.5% | – | – | – | +3.6% | -1.0% | – | – | |
| – | – | -124.0% | – | – | – | +202.6% | -3.9% | -1.8% | -664.1% | – | – | – | |
| – | -30.0% | +20.9% | +8.0% | +6.3% | +27.3% | -31.5% | -5.1% | +3.6% | +27.4% | -0.9% | +6.7% | – | |
| – | -88.3% | +663.6% | +6.3% | +29.8% | -33.0% | +21.0% | -2.1% | -15.0% | -47.5% | +80.7% | +9.8% | – | |
| – | -48.1% | +65.5% | +7.4% | +13.7% | +5.5% | -19.4% | -4.1% | -2.9% | +13.9% | -1.0% | +11.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +50.0% | -33.3% | +50.0% | -33.3% | +0.0% | -100.0% | – | +100.0% | -50.0% | +1,400.0% | -93.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +205.7% | -96.5% | -157.1% | – | – | -65.3% | +43.5% | -34.0% | -383.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.